According to the latest updates, vaccine candidates being developed by AstraZeneca and the University of Oxford, Chinese company Sinopharm and another Chinese drugmaker Sinovac Biotech have all reached phase three of human trials. Here is the latest update:
According to the latest updates, vaccine candidates being developed by AstraZeneca and the University of Oxford, Chinese company Sinopharm and another Chinese drugmaker Sinovac Biotech have all reached phase three of human trials. Here is the latest update:
0 comments